African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.

Home / Healthcare and public health research, News / African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.

African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.

May 7, 2021 Dario Scaramuzzi 0 Comments 16 tags

The symposium, organised by The Embassy of Good Science, in collaboration with EUREC, BERC-Luso, AfriEthique, and LiberHetica, aims to facilitate the sharing of experiences and perspectives on research ethics assessment challenges between African and European experts. The symposium is organized into four sessions in which experts will present on challenges and solutions related to the theme of their session. A panel discussion will follow the speaker presentations https://bit.ly/3tqlS9H.

The symposium will be live streamed here (no registration required):

https://zoom.us/j/92564963152?pwd=M3JnYWNYNEU2eVYrR3NrUG5vSWR1QT09

Passcode: sN6yzc

Explore More

SUPER

The SUPER project will provide capacity building at the regulatory and ethics level for National Regulatory Authority, National and Institutional Ethics Committees, with the ultimate goal to strengthen an environement

Directorate General Development and Cooperation – EuropeAid was formed on 1 January 2011 following the merger of the EuropeAid Cooperation Office (AIDCO) with the Directorate General for Development and Relations with African, Caribbean

As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO),

African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.

Leave a Reply Cancel reply

Explore More

SUPER

EuropeAid, from EU – a major financial resource for overseas humanitarian projects

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)